Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check [0.03%]
来自18F-FDG PET的总体代谢肿瘤体积测量：现实检查
Ronald Boellaard,Gerben J C Zwezerijnen,Irène Buvat et al.
Ronald Boellaard et al.
Measuring total metabolic tumor volume (TMTV) on 18F-FDG PET/CT images in clinical practice requires a fast, reliable, and easy-to-perform multilesional segmentation workflow. We conducted a field test to derive total metabolic volumes usin...
Tumor Asphericity in FDG PET Is an Independent Prognostic Parameter Improving Risk Stratification in Patients with Head and Neck Squamous Cell Carcinoma [0.03%]
FDG PET肿瘤非球形是头颈鳞状细胞癌患者改善风险分层的独立预后参数
Patrick Hausmann,Sebastian Zschaeck,Christian Furth et al.
Patrick Hausmann et al.
Tumor asphericity in 18F-FDG PET is a prognostic marker that has been investigated in small pilot studies of patients with head and neck squamous cell carcinoma (HNSCC). Here, we investigated the prognostic role of asphericity in a large mu...
The Use of Maximum-Intensity Projections and Deep Learning Adds Value to the Fully Automatic Segmentation of Lesions Avid for [18F]FDG and [68Ga]Ga-PSMA in PET/CT [0.03%]
最大强度投影和深度学习在[18F]FDG和[68Ga]Ga-PSMA的PET/CT病灶自动分割中的应用价值
Cláudia S Constantino,Francisco P M Oliveira,Marisa Machado et al.
Cláudia S Constantino et al.
This study investigated the added value of using maximum-intensity projection (MIP) images for fully automatic segmentation of lesions using deep learning (DL) in [18F]FDG and [68Ga]Ga-prostate-specific membrane antigen (PSMA) PET/CT scans....
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer [0.03%]
首次人体研究（Phase 0）：AB001在转移性去势抵抗性前列腺癌患者中的应用，一种针对前列腺特异性膜抗原的212铅放射配体
Kjetil Berner,Eivor Hernes,Monika Kvassheim et al.
Kjetil Berner et al.
AB001, a prostate-specific membrane antigen (PSMA)-targeted small molecule labeled with the in vivo-generating α-emitter 212Pb, was investigated in a phase 0 trial in patients with metastatic castration-resistant prostate cancer (mCRPC). T...
Murray B Reed,Matej Murgaš,Rupert Lanzenberger et al.
Murray B Reed et al.
Safety and Efficacy of 20 Cycles of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer [0.03%]
[177Lu]Lu-PSMA-617用于转移性去势抵抗性前列腺癌的安全性和疗效研究（多达20个周期）
Kerry E Jewell,James P Buteau,Elizabeth Medhurst et al.
Kerry E Jewell et al.
Development and Validation of a 18F-Flortaucipir PET Visual Stratification Method [0.03%]
18F-氟罗他西肽PET可视化分层方法的开发与验证
Ilke Tunali,Jian Wang,Anupa K Arora et al.
Ilke Tunali et al.
Tau PET quantitation methods have been used in research settings and clinical trials to measure tau burden for diagnostic, staging, and prognostic purposes. However, these methods require specialized software, skilled analysts, and advanced...
Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories [0.03%]
放射性碘治疗对乳头状和滤泡状甲状腺癌患者长期相对生存的影响：基于SEER的包含组织学亚型和复发风险类别的研究
Henning Weis,Jasmin Weindler,Katharina Schmidt et al.
Henning Weis et al.
For patients with differentiated thyroid cancer (DTC), that is, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), the American Thyroid Association and European Thyroid Association generally recommend radioactive iodine (RA...
Reply to "The Value of Functional PET in Quantifying Neurotransmitter Dynamics" [0.03%]
对《功能性PET在量化神经递质动力学中的价值》的评论
Evan D Morris,Gaelle M Emvalomenos,Jocelyn Hoye et al.
Evan D Morris et al.
18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Metaanalysis [0.03%]
18F-氟雌二醇PET / CT预测激素治疗在雌激素受体阳性乳腺癌患者的疗效：系统评价和荟萃分析
Ashwin Singh Parihar,Sofia Vaz,Siobhan Sutcliffe et al.
Ashwin Singh Parihar et al.
18F-fluoroestradiol (18F-FES) PET/CT has been investigated as a potential biomarker to predict response to endocrine therapies in patients with estrogen receptor (ER)-positive breast cancer. Although previous findings were promising, most h...